Cargando…
Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy (PML) is a rare, potentially devastating myelin-degrading disease caused by the JC virus. PML occurs preferentially in patients with compromised immune system, but has been also observed in multiple sclerosis (MS) patients treated with disease-modifying dru...
Autores principales: | Bertoli, Diego, Sottini, Alessandra, Capra, Ruggero, Scarpazza, Cristina, Bresciani, Roberto, Notarangelo, Luigi D., Imberti, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851145/ https://www.ncbi.nlm.nih.gov/pubmed/31719595 http://dx.doi.org/10.1038/s41598-019-53010-x |
Ejemplares similares
-
Pre-Existing T- and B-Cell Defects in One Progressive Multifocal Leukoencephalopathy Patient
por: Sottini, Alessandra, et al.
Publicado: (2012) -
Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry
por: Prosperini, Luca, et al.
Publicado: (2016) -
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients
por: Chiarini, Marco, et al.
Publicado: (2020) -
Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene
por: Bertoli, Diego, et al.
Publicado: (2015) -
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
por: Hatchwell, Eli, et al.
Publicado: (2022)